Stock listing
OTC:CHGCY Chugai Pharmaceutical Co., Ltd. Stock
US listing (OTC) of Chugai Pharmaceutical Co., Ltd. · home listing Tokyo:4519
Follow Chugai Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Share price · OTC:CHGCY
$22.26 USD -0.20 (-0.9%)
Close on Nov 20, 2026
- Day range
- $22.01 – $22.81 USDNov 20, 2026
- Volume
- 218,409 sharesNov 20, 2026
- Market cap
- $73.27B USDAt the close on Nov 20, 2026 · price × 3.29B shares outstanding
- 52-week range
- $18.96 – $33.48 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $6.76M USDMedian day 236,468 shares · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:CHGCY | $22.26 USD | -0.20 (-0.9%) | 218,409 | $22.81 | $22.81 | $22.01 | $22.46 | Close on Nov 20, 2026 |
| OTC:CHGCF | $44.81 USD | +0.488 (+1.1%) | 561 | $44.81 | $44.81 | $44.81 | $44.32 | Close on Nov 20, 2026 |
| Frankfurt:CUP | €40.51 EUR | -0.67 (-1.6%) | — | €40.54 | €40.65 | €40.51 | €41.18 | Close on Nov 20, 2026 |
| Munich:CUP | €40.08 EUR | -1.67 (-4.0%) | — | €40.64 | €40.64 | €40.08 | €41.75 | Close on Nov 20, 2026 |
| Dusseldorf:CUP | €39.61 EUR | -1.17 (-2.9%) | — | €40.09 | €40.58 | €39.61 | €40.78 | Close on Nov 20, 2026 |
| Frankfurt:CUP0 | €19.50 EUR | -0.40 (-2.0%) | — | €19.50 | €19.50 | €19.50 | €19.90 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · OTC:CHGCY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $21.58 | -1.192 | -5.2% | $21.00 | $21.82 | $21.00 | 210,842 | |
| $22.77 | +1.013 | +4.7% | $22.77 | $22.77 | $22.77 | 902,434 | |
| $21.76 | +0.165 | +0.8% | $21.76 | $21.76 | $21.76 | 148,308 | |
| $21.59 | -0.078 | -0.4% | $21.59 | $21.59 | $21.59 | 114,545 | |
| $21.67 | +0.013 | +0.1% | $21.67 | $21.67 | $21.67 | 190,116 | |
| $21.66 | +0.582 | +2.8% | $21.66 | $21.66 | $21.66 | 150,275 | |
| $21.08 | +0.177 | +0.8% | $21.08 | $21.08 | $21.08 | 222,649 | |
| $20.90 | -0.283 | -1.3% | $20.90 | $20.90 | $20.90 | 128,079 | |
| $21.18 | -0.70 | -3.2% | $21.18 | $21.18 | $21.18 | 126,322 | |
| $21.88 | +0.21 | +1.0% | $21.88 | $21.88 | $21.88 | 324,605 | |
| $21.67 | +0.638 | +3.0% | $21.67 | $21.67 | $21.67 | 161,510 | |
| $21.04 | +0.444 | +2.2% | $21.04 | $21.04 | $21.04 | 540,497 | |
| $20.59 | +0.238 | +1.2% | $20.59 | $20.59 | $20.59 | 180,343 | |
| $20.35 | +0.365 | +1.8% | $20.35 | $20.35 | $20.35 | 408,560 | |
| $19.99 | -0.125 | -0.6% | $19.99 | $19.99 | $19.99 | 335,808 | |
| $20.11 | +0.291 | +1.5% | $20.11 | $20.11 | $20.11 | 2,276,211 | |
| $19.82 | +0.811 | +4.3% | $19.82 | $19.82 | $19.82 | 547,052 | |
| $19.01 | -0.467 | -2.4% | $19.01 | $19.01 | $19.01 | 336,156 | |
| $19.48 | +0.514 | +2.7% | $19.48 | $19.48 | $19.48 | 482,816 | |
| $18.96 | -0.034 | -0.2% | $18.96 | $18.96 | $18.96 | 278,741 | |
| $19.00 | -0.302 | -1.6% | $19.00 | $19.00 | $19.00 | 327,359 | |
| $19.30 | +0.006 | 0.0% | $19.30 | $19.30 | $19.30 | 555,148 | |
| $19.29 | -0.065 | -0.3% | $19.29 | $19.29 | $19.29 | 265,882 | |
| $19.36 | +0.085 | +0.4% | $19.36 | $19.36 | $19.36 | 350,636 | |
| $19.27 | +0.146 | +0.8% | $19.27 | $19.27 | $19.27 | 250,429 | |
| $19.13 | -0.445 | -2.3% | $19.13 | $19.13 | $19.13 | 794,244 | |
| $19.57 | -0.235 | -1.2% | $19.57 | $19.57 | $19.57 | 880,807 | |
| $19.81 | +0.466 | +2.4% | $19.81 | $19.81 | $19.81 | 197,981 | |
| $19.34 | -0.848 | -4.2% | $19.34 | $19.34 | $19.34 | 215,259 | |
| $20.19 | -0.858 | -4.1% | $20.19 | $20.19 | $20.19 | 373,301 | |
| $21.05 | +0.123 | +0.6% | $21.05 | $21.05 | $21.05 | 267,475 | |
| $20.93 | -0.394 | -1.8% | $20.93 | $20.93 | $20.93 | 228,851 | |
| $21.32 | -0.128 | -0.6% | $21.32 | $21.32 | $21.32 | 146,476 | |
| $21.45 | +0.028 | +0.1% | $21.45 | $21.45 | $21.45 | 117,962 | |
| $21.42 | -0.007 | 0.0% | $21.42 | $21.42 | $21.42 | 160,928 | |
| $21.43 | -0.032 | -0.1% | $21.43 | $21.43 | $21.43 | 219,494 | |
| $21.46 | +0.68 | +3.3% | $21.46 | $21.46 | $21.46 | 278,264 | |
| $20.78 | -0.18 | -0.9% | $20.78 | $20.78 | $20.78 | 221,870 | |
| $20.96 | +0.231 | +1.1% | $20.96 | $20.96 | $20.96 | 907,760 | |
| $20.73 | -0.196 | -0.9% | $20.73 | $20.73 | $20.73 | 301,525 | |
| $20.92 | +0.074 | +0.4% | $20.92 | $20.92 | $20.92 | 271,743 | |
| $20.85 | -0.282 | -1.3% | $20.85 | $20.85 | $20.85 | 321,059 | |
| $21.13 | -0.075 | -0.4% | $21.13 | $21.13 | $21.13 | 232,810 | |
| $21.21 | -0.555 | -2.6% | $21.21 | $21.21 | $21.21 | 187,077 | |
| $21.76 | -0.367 | -1.7% | $21.76 | $21.76 | $21.76 | 70,223 | |
| $22.13 | +0.604 | +2.8% | $22.13 | $22.13 | $22.13 | 281,890 | |
| $21.52 | -0.133 | -0.6% | $21.52 | $21.52 | $21.52 | 203,234 | |
| $21.66 | +0.013 | +0.1% | $21.66 | $21.66 | $21.66 | 152,420 | |
| $21.64 | -0.353 | -1.6% | $21.64 | $21.64 | $21.64 | 230,891 | |
| $22.00 | +0.195 | +0.9% | $22.00 | $22.00 | $22.00 | 117,081 | |
| $21.80 | -0.315 | -1.4% | $21.80 | $21.80 | $21.80 | 132,246 | |
| $22.12 | +0.297 | +1.4% | $22.12 | $22.12 | $22.12 | 104,448 | |
| $21.82 | -0.125 | -0.6% | $21.82 | $21.82 | $21.82 | 173,122 | |
| $21.95 | -0.107 | -0.5% | $21.95 | $21.95 | $21.95 | 263,006 | |
| $22.05 | -0.318 | -1.4% | $22.05 | $22.05 | $22.05 | 247,876 | |
| $22.37 | +0.634 | +2.9% | $22.37 | $22.37 | $22.37 | 240,126 |
Splits
1 split · OTC:CHGCY · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 12-for-1 | Split |
- Ticker
- OTC:CHGCY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Supplementary Materials Consolidated Financial Statements for the nine months ended September 30, 2026 (IFRS)
Latest earnings call · Jul 24, 2026
Chugai Pharmaceutical (Tokyo:4519) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Q3 2026 Earnings Presentation
Earnings · 32 slides
Latest news
Supplementary Materials Consolidated Financial Statements for the nine months ended September 30, 2026 (IFRS)
Oct 27, 2026
Closed $21.18 (-3.2%) on Oct 27, 2026
CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the nine months ended September 30, 2026)
Oct 27, 2026
Closed $21.18 (-3.2%) on Oct 27, 2026
F. Hoffmann-La Roche Announces Third Quarter Sales 2026
Oct 22, 2026
Closed $21.04 (+2.2%) on Oct 22, 2026
Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Obesity, Return of License and Resumption of Development for SMA
Sep 28, 2026
Closed $20.19 (-4.1%) on Sep 28, 2026
Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors
Sep 9, 2026
Closed $21.13 (-0.4%) on Sep 9, 2026
Chugai and GSK Sign Exclusive License Agreement for Anti-Dengue Virus Antibody AID351
Aug 18, 2026
Closed $21.46 (-0.4%) on Aug 18, 2026
Chugai Announces 2026 2nd Quarter Results
Jul 27, 2026
Closed $20.91 (-7.6%) on Jul 27, 2026
CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026)
Jul 24, 2026
Closed $22.65 (+2.9%) on Jul 24, 2026
F. Hoffmann-La Roche Announces Half Year Results 2026
Jul 23, 2026
Closed $22.00 (-1.8%) on Jul 23, 2026
Chugai Files New Drug Application in Japan for Sparsentan for the Treatment of IgA Nephropathy
Jun 22, 2026
Closed $23.32 (-0.9%) on Jun 22, 2026
Chugai Pharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 25 in the last 12 months · 31 in all · newest Oct 27, 2026 · oldest 2025
- Calls
- 9 calls with a replay · 9 with a transcript · latest Jul 24, 2026
- Decks
- 107 decks · latest Oct 27, 2026
Where Chugai Pharmaceutical Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4519 中外製薬 · Home listing | Tokyo | Japan | JPY |
| OTC:CHGCY · This page | OTC | United States | USD |
| OTC:CHGCF | OTC | United States | USD |
| gettex:CUP | gettex | Germany | EUR |
| Frankfurt:CUP | Frankfurt | Germany | EUR |
| Tradegate:CUP | Tradegate | Germany | EUR |
| LS Exchange:857216 | LS Exchange | Germany | EUR |
| Lang & Schwarz:857216 | Lang & Schwarz | Germany | EUR |
| BMV:4519N | BMV | Mexico | MXN |
| Munich:CUP | Munich | Germany | EUR |
| Stuttgart:CUP | Stuttgart | Germany | EUR |
| Hamburg:CUP | Hamburg | Germany | EUR |
| Dusseldorf:CUP | Dusseldorf | Germany | EUR |
| gettex:CUP0 | gettex | Germany | EUR |
| Hanover:CUP | Hanover | Germany | EUR |
| BIVA:4519N | BIVA | Mexico | MXN |
| Frankfurt:CUP0 | Frankfurt | Germany | EUR |
| Munich:CUP0 | Munich | Germany | EUR |
Team and board
Officers
| Officer | Role |
|---|---|
| Osamu Okuda | Representative Director, President & CEO |
| Iwaaki Taniguchi | Director, Executive Vice President & CFO |
| Hitoshi Iikura | Director, Executive Vice President |
| Boris L. Zaïtra | Head of Corporate Business Development of Roche |
Board
| Director | Role |
|---|---|
| Boris L. Zaïtra | Head of Corporate Business Development of Roche |
| Hitoshi Iikura | Director, Executive Vice President |
| Iwaaki Taniguchi | Director, Executive Vice President & CFO |
| Masayoshi Higuchi | Audit & Supervisory Board Member (full-time) |
| Osamu Okuda | Representative Director, President & CEO |
| Shigehiro Yamada | Audit & Supervisory Board Member (full-time) |
| Teresa A. Graham | Director |
| Thomas Schinecker | Director |
Events
| Call | When | Status |
|---|---|---|
| Chugai Pharmaceutical (Tokyo:4519) Q2 2026 Earnings Call | Fri, Jul 24, 2026 · 3:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q1 2026 Earnings Call | Fri, Apr 24, 2026 · 5:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q4 2025 Earnings Call | Thu, Jan 29, 2026 · 3:30 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q3 2025 Earnings Call | Sat, Oct 25, 2025 · 5:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q2 2025 Earnings Call | Thu, Jul 24, 2025 · 4:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q4 2024 Earnings Call | Thu, Jan 30, 2025 · 3:30 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q3 2024 Earnings Call | Fri, Oct 25, 2024 · 5:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q2 2024 Earnings Call | Wed, Jul 24, 2024 · 4:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q1 2024 Earnings Call | Wed, Apr 24, 2024 · 5:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 32 slides | Oct 27, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 32 slides | Oct 27, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 34 slides | Jul 24, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 34 slides | Jul 24, 2026 |
| Technical Presentation (June 2026) | Technical | 45 slides | Jun 17, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 34 slides | Apr 24, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 53 slides | Jan 29, 2026 |
| Q2 2025 Earnings Presentation | Earnings | 47 slides | Jul 24, 2025 |
| souzoulabo slide | 6 slides | February 2025 | |
| FY2024 Earnings Presentation | Earnings | 56 slides | Jan 30, 2025 |
Show 50 decks
This page holds 50 of 107 decks. Open Decks
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the nine months ended September 30, 2026) | Oct 27, 2026 | Results | Tokyo Stock Exchange |
| Supplementary Materials Consolidated Financial Statements for the nine months ended September 30, 2026 (IFRS) | Oct 27, 2026 | Results | Tokyo Stock Exchange |
| F. Hoffmann-La Roche Announces Third Quarter Sales 2026 | Oct 22, 2026 | Other filings | Tokyo Stock Exchange |
| Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Obesity, Return of License and Resumption of Development for SMA | Sep 28, 2026 | Other filings | Tokyo Stock Exchange |
| CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026) | Jul 24, 2026 | Interim report | Tokyo Stock Exchange |
| F. Hoffmann-La Roche Announces Half Year Results 2026 | Jul 23, 2026 | Interim report | Tokyo Stock Exchange |
Cap table
Built by 6ix from Chugai Pharmaceutical Co., Ltd.’s releases
- Common shares
- 1,679,057,667
- Fully diluted
- 1,679,057,667
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,679,057,667 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,679,057,667 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Boris L. Zaïtra | Head of Corporate Business Development of Roche · Since at least Mar 27, 2026 |
| Hitoshi Iikura | Director, Executive Vice President · Since at least Mar 27, 2026 |
| Iwaaki Taniguchi | Director, Executive Vice President & CFO · Since at least Mar 27, 2026 |
| Masayoshi Higuchi | Audit & Supervisory Board Member (full-time) · Since at least Nov 5, 2026 |
| Osamu Okuda | Representative Director, President & CEO · Since at least Sep 9, 2026 |
| Shigehiro Yamada | Audit & Supervisory Board Member (full-time) · Since at least Nov 5, 2026 |
| Teresa A. Graham | Director · Since at least Mar 27, 2026 |
| Thomas Schinecker | Director · Since at least Mar 27, 2026 |
Log in to ask 6ix AI your own questions about Chugai Pharmaceutical Co., Ltd.